Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 21, 2012
Time to onset of antifracture efficacy and year-by-year persistence of effect of zoledronic acid in women with osteoporosisSteven Boonen, Richard Eastell, Guoqin Su, et al.The Journal of Clinical Endocrinology and Metabolism|July 2, 2009
Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral densityRichard Eastell, Dennis M Black, Steven Boonen, et al.BMC Medical Research Methodology|August 15, 2022
On model-based time trend adjustments in platform trials with non-concurrent controlsMarta Bofill Roig, Pavla Krotka, Carl-Fredrik Burman, et al.The New England Journal of Medicine|September 2, 2005
Comparison of a single infusion of zoledronic acid with risedronate for Paget's diseaseIan R Reid, Paul Miller, Kenneth Lyles, et al.Current Medical Research and Opinion|June 18, 2004
The HORIZON Recurrent Fracture Trial: design of a clinical trial in the prevention of subsequent fractures after low trauma hip fracture repairCathleen S Colón-Emeric, John Caminis, Theodore T Suh, et al.Journal of the American Dental Association (1939)|January 3, 2008
Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trialJohn T Grbic, Regina Landesberg, Shou-Qing Lin, et al.Lancet (London, England)|April 14, 2009
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trialDavid M Reid, Jean-Pierre Devogelaer, Kenneth Saag, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2009
Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fractureErik Fink Eriksen, Kenneth W Lyles, Cathleen S Colón-Emeric, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 20, 2014
Subgroup variations in bone mineral density response to zoledronic acid after hip fractureJay S Magaziner, Denise L Orwig, Kenneth W Lyles, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 26, 2007
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structureRobert R Recker, Pierre D Delmas, Johan Halse, et al.Pageof 4